The mission of the UW?Madison CBIT program is (i) to train graduate students to recognize and address problems that transcend the traditional boundaries of chemistry and biology using innovative and rigorous approaches, (ii) to provide professional development skills and career guidance that maximize the impact of student training, and (iii) to develop an inclusive and supportive community of engaged scholars working at the chemistry?biology interface. This renewal application requests support for 10 predoctoral trainees per year, with each trainee appointed to the program for two years. Key themes are underscored below: ! Our CBIT program will help train the next generation of the biomedical research workforce. We seek to provide cross-disciplinary research training to our students, so that biologists not only appreciate, but also use, the tools and techniques developed by chemists, and vice versa. It is these fresh approaches that can provide breakthroughs in science. We will provide students with foundational course work in chemical biology and teach our students the value of looking at research problems from alternate perspectives. ! We will give our students the professional skills to maximize their cross-disciplinary training in the laboratory. These professional tools will include guidance in scientific communication to diverse audiences, the responsible conduct of research, the rigorous analysis of scientific data, and career opportunities beyond academia. We then will provide opportunities for the trainees to advance their careers through the application of these tools, through outreach, an internship, and scientific conferences. ! We will build an engaged and inclusive community of scientists working at the chemistry?biology interface. Through regular interactions with trainees and trainers, we will leverage the strong interactions between faculty/departments on campus and create new scientific collaborations. In turn, we will build strong mentor/mentee relationships between our cohort of students and faculty via formal training in mentorship. ! We understand that a diversity of experience enriches the research enterprise. Throughout the pursuit of the CBIT program?s goals, we will fully commit to the inclusion of qualified students from all backgrounds. The next award period will build substantially on the strong foundation developed over the 25-year history of the CBIT grant at UW?Madison. We will enhance existing training elements, maintaining those features that have proven successful, modernizing others and implementing new features to ensure alignment with proposed alterations to the mission of the NIGMS T32 program, and streamlining current and new features in order to empower, rather than overburden, our trainees. The outcome of the UW?Madison CBIT program will be a diverse pool of expertly trained scientists who have the broad base of technical and professional skills necessary for them to contribute substantively to the biomedical workforce. Lastly, we will evaluate our ability to achieve this outcome through the implementation of the first quantitative assessment of the CBIT program.
The Chemistry-Biology Interface Training (CBIT) Program is a unique graduate training program at the University of Wisconsin?Madison centered on an appreciation of the blending of chemical and biological methods to solve biomedical problems. The mission of the CBIT Program is to train graduate students to address research problems that transcend the traditional boundaries of chemistry and biology using innovative and rigorous approaches, to provide professional development skills and career guidance to maximize the impact of their training, and to develop an inclusive and supportive community of engaged scholars working at the chemistry-biology interface. This cross-disciplinary training is ideal preparation for designing, discovering, and developing the next generation of therapies that will directly impact human health.
| Ehlerding, Emily B; Lan, Xiaoli; Cai, Weibo (2018) Predicting PD-1/PD-L1 status in bladder cancer with 18F-FDG PET? Eur J Nucl Med Mol Imaging : |
| Wei, Weijun; Ehlerding, Emily B; Lan, Xiaoli et al. (2018) PET and SPECT imaging of melanoma: the state of the art. Eur J Nucl Med Mol Imaging 45:132-150 |
| Wei, Weijun; Jiang, Dawei; Ehlerding, Emily B et al. (2018) Noninvasive PET Imaging of T cells. Trends Cancer 4:359-373 |
| Ehlerding, Emily B; Lan, Xiaoli; Cai, Weibo (2018) ""Albumin Hitchhiking"" with an Evans Blue Analog for Cancer Theranostics. Theranostics 8:812-814 |
| Kang, Lei; Jiang, Dawei; Ehlerding, Emily B et al. (2018) Noninvasive Trafficking of Brentuximab Vedotin and PET Imaging of CD30 in Lung Cancer Murine Models. Mol Pharm 15:1627-1634 |
| Ehlerding, Emily B; Lacognata, Saige; Jiang, Dawei et al. (2018) Targeting angiogenesis for radioimmunotherapy with a 177Lu-labeled antibody. Eur J Nucl Med Mol Imaging 45:123-131 |
| Zhan, Yonghua; Ehlerding, Emily B; Shi, Sixiang et al. (2018) Intrinsically Zirconium-89-Labeled Manganese Oxide Nanoparticles for In Vivo Dual-Modality Positron Emission Tomography and Magnetic Resonance Imaging. J Biomed Nanotechnol 14:900-909 |
| Ehlerding, Emily B; Grodzinski, Piotr; Cai, Weibo et al. (2018) Big Potential from Small Agents: Nanoparticles for Imaging-Based Companion Diagnostics. ACS Nano 12:2106-2121 |
| Ehlerding, Emily B; Ferreira, Carolina A; Aluicio-Sarduy, Eduardo et al. (2018) 86/90Y-Based Theranostics Targeting Angiogenesis in a Murine Breast Cancer Model. Mol Pharm 15:2606-2613 |
| Reidenbach, Andrew G; Kemmerer, Zachary A; Aydin, Deniz et al. (2018) Conserved Lipid and Small-Molecule Modulation of COQ8 Reveals Regulation of the Ancient Kinase-like UbiB Family. Cell Chem Biol 25:154-165.e11 |
Showing the most recent 10 out of 258 publications
